• NICE no for Pierre Fabre's Braftovi pharmatimes
    September 17, 2020
    The National Institute for Health and Care Excellence has published the outcome of an appraisal of Pierre Fabre's Braftovi (encorafinib), turning down NHS funding for the drug as a treatment for some patients with advanced colorectal cancer.
PharmaSources Customer Service